In the extensive debate surrounding recombinant DNA research, the significant contributions it has already made and their potential for directly affecting medical practice are often lost The recombinant techniques are described in the context of the already achieved“manufacture”of highly pure insulin and human growth hormone and their promise for practical application in diagnosis and therapy.